Symposium III: Cannabis and Cannabinoids – From Science to Practice to Policy: An International Perspective-Cannabis and Cannabinoids - From Science to Practice to Policy: An International Perspective

Video Transcription

Video Summary

In this video, the first part focuses on the conference and symposium introduction, including information on recording availability, CME credit, and slide availability. Dr. Gregory Bunt presents on cannabinoids and addiction psychiatry, discussing the distinctions between cannabinoids, their therapeutic effects like CBD for opiate withdrawal and pain, and adverse effects such as THC's impact on young adults. Dr. Bernard LeFoll discusses the potential of the endocannabinoid system in modulating brain function and presents clinical trials on cannabinoid drugs for mental health disorders. Dr. Jack Janna-Kosin provides insights into the Dutch cannabis policy, history, and current regulation, highlighting the importance of evidence-based research in shaping cannabis use policies.<br /><br />In the second part of the video, the speaker explores the Dutch cannabis policy and its impact on individual health and research. They discuss addiction risk and resilience, the interaction between the brain and environment, and ongoing research comparing cannabis addicts from Texas and Amsterdam. They address treatment demands for cannabis dependence in the Netherlands despite decriminalization and emphasize the need for knowledge about cannabis harms and benefits, as well as the impact of policy measures.<br /><br />The speaker discusses current issues with the Dutch cannabis policy, such as illegal production and stocking, lack of quality testing, and slow progress in establishing a closed cultivation-to-selling circuit. They also touch upon medical cannabis use and the limited availability of research-grade cannabis. The conclusion emphasizes the importance of improving cannabis science, standardized measures and terminology, and conducting more research on the positive effects of cannabis and its effectiveness in treating mental health problems.<br /><br />Overall, the video provides an overview of cannabinoids and addiction psychiatry, clinical trials on cannabinoid drugs for mental health disorders, and insights into the Dutch cannabis policy and its impact on individual health and research.

Keywords

conference introduction

symposium introduction

recording availability

CME credit

slide availability

cannabinoids

addiction psychiatry

CBD

opiate withdrawal

THC

endocannabinoid system

clinical trials

mental health disorders

Dutch cannabis policy

individual health

	The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.		400 Massasoit Avenue Suite 108 East Providence, RI 02914 cmecpd@aaap.org Privacy	About Advocacy Membership Fellowship Education and Resources Training Events